Showing 5641-5650 of 6035 results for "".
- Study: 3D Printed Artificial Corneas Similar to Human Oneshttps://modernod.com/news/study-3d-printed-artificial-corneas-similar-to-human-ones/2476615/When a person has a severely damaged cornea, a corneal transplant is required. However, there are 2,000 patients waiting for the cornea donation in the country as of 2018, and they wait for 6 or more years on average for the donation. For this reason, many scientists have put their efforts in dev
- Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitishttps://modernod.com/news/central-retinal-vein-occlusion-rarely-complicates-ulcerative-colitis/2476609/Central retinal vein occlusion (CRVO) can rarely complicate the course of inflammatory bowel disease (IBD), according to a case series, as reported by Reuters. As many as 11.8% of patients with IBD can develop ophthalmological compl
- RAZ Mobility Launches Accessible Mobile Phone for Individuals with Impaired Visionhttps://modernod.com/news/raz-mobility-launches-accessible-mobile-phone-for-individuals-with-impaired-vision/2476607/RAZ Mobility has announced the launch of the Lucia, a mobile phone specifically designed to address the unique needs of people who are blind, low vision, or hard of hearing. Someone who is completely blind can use Lucia just as fully and effectively as someone who is sighted. According to
- Biophytis Files Registration Statement for Proposed Initial Public Offering in the United Stateshttps://modernod.com/news/biophytis-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/2476604/Biophytis announced that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) in relation to a proposed initial public offering of American Depositary Shares representing ordinary shares of Biophytis. Biophytis has applied to list its shares
- Zeiss Ranked Best Company in Germany’s Public Value Atlashttps://modernod.com/news/zeiss-ranked-best-company-in-germanys-public-value-atlas/2476600/Zeiss is Germany’s highest-ranked company in the 2019 Public Value Atlas (Gemeinwohlatlas 2019). The announcement was made in Berlin by the authors of the study, the Center for Leadership and Values in Society at the University of St. Gallen (CLVS-HSG) in cooperation with the Dr. Arend Oetk
- Ocular Therapeutix OTX-TP Intracanalicular Insert Fails to Meet Phase 3 Endpointhttps://modernod.com/news/ocular-therapeutix-otx-tp-intracanalicular-insert-fails-to-meet-phase-3-endpoint/2476598/Ocular Therapeutix’s intracanalicular insert failed to meet its primary endpoint of statistically significant superiority in mean reduction of IOP compared with placebo at all nine time points, according to a company news release. OTX-TP is an intracanalicular insert that delivers a
- Surgical Specialties Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedureshttps://modernod.com/news/surgical-specialties-launches-caliber-ophthalmics-division-to-focus-on-global-growth-of-ophthalmic-surgical-procedures/2476597/Surgical Specialties Corporation (SSC) announced the launch of Caliber Ophthalmics, a new business division that combines SSC’s Sharpoint brand with its two recent ophthalmic acquisitions, Unique Technologies and VPM Surgical. To lead the Caliber Ophthalmics division, SSC has named <
- Patients Equally Pleased With Different Keratoplasty Approacheshttps://modernod.com/news/patients-equally-pleased-with-different-keratoplasty-approaches/2476586/Although the Descemet Endothelial Thickness Comparison Trial (DETECT) showed better visual acuity with a newer, more demanding corneal transplantation method, this did not translate into greater patient satisfaction, according to a secondary analysis of outcome data, as
- Allegro Announces Positive Results of Ex-US Proof-of-Concept Trial With ALG-1007 for Dry Eye Diseasehttps://modernod.com/news/allegro-ophthalmics-announces-positive-results-of-ex-us-proof-of-concept-trial-with-integrin-inhibitor-alg-1007-for-dry-eye-disease/2476583/Allegro Ophthalmics announced positive results of an ex-US proof-of-concept clinical trial of the new investigational ALG-1007 topical drop drug candidate in patients with dry eye disease (DED). The results were presented by Eric D. Donnenfeld, MD, last week at the 2019 American Society of Catara
- PECAA Launches the Integrated Eye Care Initiativehttps://modernod.com/news/pecaa-launches-the-integrated-eye-care-initiative/2476579/PECAA, a nationwide doctor alliance group for independent eye care professionals, has launched a new program, the “Integrated Eye Care Initiative,” which is aimed at driving informed decision making for th